Incurin
Active substance
ATC code
Species
Dog (bitch).
Indications
The treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.
Dose to be administered and administration route
For oral use only.
A relationship between final effective dose and body weight has not been established and therefore the dose has to be determined for each dog on an individual basis.
The following dosing schedule is advised: start treatment with 1 tablet (1 mg estriol) every day. If treatment is successful, lower the dose to half a tablet a day. If treatment is not successful, increase the dose to 2 tablets a day to be given in one dose. Some dogs do not need daily treatment; treatment every other day may be tried, once the effective daily dose has been established.
The minimum dose given should not be less than 0.5 mg per dog per day. Ensure the dose used to achieve the therapeutic effect is as low as possible. Do not use more than 2 tablets per dog per day. If no response to treatment is obtained the diagnosis should be reconsidered in order to investigate other causes for the incontinence such as neurological disorders, bladder neoplasia, etc.
Animals should be re-examined every 6 months during treatment.
Adverse reactions
Dog (bitch):
|
Very common (>1 animal / 10 animals treated): |
Swollen vulva1,2, Mammary gland oedema1,2; Attractiveness to males1,2; Vomiting1,2 |
|
Rare (1 to 10 animals / 10,000 animals treated): |
Vaginal haemorrhage; Alopecia |
1Observed at the highest recommended dose of 2 mg per dog.
2These effects are reversible after lowering the dose.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.
TRUSTED SOURCE
